OTCMKTS:ABGBY ABGBY (ABGBY) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free ABGBY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$1.06▼$1.0650-Day Range N/A52-Week Range$0.85▼$1.42VolumeN/AAverage Volume25,140 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ABGBY alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About ABGBY Stock (OTCMKTS:ABGBY)Abengoa SA is a Spain-based company primarily engaged in the construction and engineering sector. The Company's activities are divided into three business segments: Engineering and construction, Concession-type infrastructure and Industrial production. The Engineering and construction division focuses on the execution of turnkey projects for electric generation plants, water infrastructure and transmission lines, among others. The Concession-type infrastructure division is structured into four lines: Solar, operating solar energy plants; Water, operating water utilities; Transmission, managing transmission line infrastructure, as well as Cogeneration and other, managing conventional cogeneration electricity plants. The Industrial production division includes the production and development of biofuels, mainly bioethanol. The Company operates through numerous subsidiaries in Europe, the Americas, Africa and Asia.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> ABGBY Stock News HeadlinesApril 18, 2024 | forbes.comThe ‘All In The Family’ Debut Of Texas Rangers’ Pitcher Jack LeiterApril 17, 2024 | yahoo.com‘Big Brother’ Alum Analyse Talavera Reveals Filming the Show ‘Feels Like You’re in Prison’April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 17, 2024 | msn.comCity council approves $6.5M for trail designed to connect Downtown Atlanta to Chattahoochee RiverApril 16, 2024 | sports.yahoo.comHigh school sports roundup for April 15-20April 16, 2024 | msn.comPullman Yards owner caught on video shouting, cursing at city of Atlanta contract workerApril 16, 2024 | msn.comLouis Zunguze gets nod for city manager jobApril 14, 2024 | msn.comCelebrate the world's biggest art car celebration with the 2024 Houston Art Car ParadeApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 13, 2024 | yahoo.com‘Are You the One’ Alum Geles Rodriguez Reveals Why She Doesn’t Talk to Her Former CostarsApril 13, 2024 | axios.comStudios ramp up attack on digital piracy and other CinemaCon takeawaysApril 13, 2024 | msn.comHonk! Honk! It's Art Car Parade timeApril 10, 2024 | yahoo.comWhy ‘Are You the One’ Alum Geles Rodriguez Regrets ‘Getting Intimate on Reality TV’April 10, 2024 | msn.comSt. Arnold Brewery founder gets ready for grand marshal role in Houston's Art Car ParadeApril 10, 2024 | yahoo.comBachelor in Paradise’s Serene Russell Gives Dating Update After Ending Brandon Jones EngagementApril 8, 2024 | msn.comArea briefs: Dogs begin final week of spring practice, students return to class after spring breakApril 4, 2024 | finance.yahoo.comSCREENVISION MEDIA EXTENDS EXCLUSIVE RELATIONSHIPS WITH KEY EXHIBITOR PARTNERSApril 4, 2024 | msn.comDeflowered Power: Gay punk band Pansy Division plays Atlanta on FridayApril 4, 2024 | msn.comUnlocking the Archive: Lancaster High School Percussion Ensemble performs in April 2004April 3, 2024 | msn.comAfter failed efforts, Richmond blocked from another casino voteApril 3, 2024 | msn.comCavemen, Rickie Lee Jones, Black Crowes among top Houston live events to see this weekApril 3, 2024 | sports.yahoo.comPerfect games & walk-off wins top high school action for spring season in Bucks County areaApril 2, 2024 | bizjournals.comNelson Mullins Riley & Scarborough law firm opens Houston office, hires 10 attorneysApril 2, 2024 | msn.comHouston City Council to vote to extend parking meter payment timesApril 2, 2024 | msn.comCrash with injuries reported on Bagby Road near CrittendenApril 1, 2024 | msn.comPortman’s plans for Amsterdam Walk ‘incompatible’ with Va-Hi, Morningside-Lenox aesthetic, some residents sayMarch 28, 2024 | msn.comFallen crypto tycoon Bankman-Fried gets 25-year sentenceSee More Headlines Receive ABGBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ABGBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorN/A Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:ABGBY Previous SymbolNASDAQ:ABGB CUSIPN/A CIKN/A Webwww.abengoa.com Phone+34-954-937000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (OTCMKTS:ABGBY) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABGBY Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.